T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$7.49B |
| 2 |
Micron Technology
MU
|
+$6.62B |
| 3 |
Lam Research
LRCX
|
+$3.45B |
| 4 |
Applied Materials
AMAT
|
+$3.03B |
| 5 |
Advanced Micro Devices
AMD
|
+$2.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$12.1B |
| 2 |
Apple
AAPL
|
+$11.6B |
| 3 |
Amazon
AMZN
|
+$3.54B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$3.07B |
| 5 |
Keysight
KEYS
|
+$1.82B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.73% |
| 2 | Healthcare | 11.3% |
| 3 | Financials | 10.32% |
| 4 | Communication Services | 9.66% |
| 5 | Industrials | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2201
BioLife Solutions
BLFS
$1.88B
| $1.29M | ﹤0.01% |
45,713
+5,418
| +13% | +$127K |
|
2202
UroGen Pharma
URGN
$2.02B
| $1.29M | ﹤0.01% |
35,003
+6,549
| +23% | +$177K |
|
|
INFQ
2203
Infleqtion Inc
INFQ
$3.27B
| $1.29M | ﹤0.01% |
+96,676
| New | +$1.33M |
|
2204
Bank First Corp
BFC
$1.69B
| $1.28M | ﹤0.01% |
8,624
+1,286
| +18% | +$184K |
|
2205
SandRidge Energy
SD
$514M
| $1.28M | ﹤0.01% |
93,258
+19,298
| +26% | +$288K |
|
2206
Castle Biosciences
CSTL
$1.09B
| $1.27M | ﹤0.01% |
53,242
+15,450
| +41% | +$344K |
|
|
DMRA
2207
Damora Therapeutics
DMRA
$1.28B
| $1.27M | ﹤0.01% |
+48,743
| New | +$1.18M |
|
|
WSR
2208
DELISTED
Whitestone REIT
WSR
| $1.26M | ﹤0.01% |
66,593
+3,669
| +6% | +$68.9K |
|
2209
Kopin
KOPN
$928M
| $1.26M | ﹤0.01% |
280,944
+40,192
| +17% | +$175K |
|
|
AUGO
2210
Aura Minerals Inc
AUGO
$7.01B
| $1.26M | ﹤0.01% |
+20,013
| New | +$1.58M |
|
2211
TriMas Corp
TRS
$1.4B
| $1.26M | ﹤0.01% |
27,919
-685
| -2% | -$27.3K |
|
|
BRSP
2212
BrightSpire Capital
BRSP
$517M
| $1.25M | ﹤0.01% |
230,270
+38,480
| +20% | +$221K |
|
2213
Revolve Group
RVLV
$1.51B
| $1.25M | ﹤0.01% |
54,805
+11,832
| +28% | +$262K |
|
2214
Unitil
UTL
$930M
| $1.25M | ﹤0.01% |
23,755
+1,931
| +9% | +$100K |
|
|
TIC
2215
TIC Solutions Inc
TIC
$1.94B
| $1.25M | ﹤0.01% |
154,455
+9,899
| +7% | +$83.5K |
|
2216
Agilon Health
AGL
$1.36B
| $1.25M | ﹤0.01% |
+11,606
| New | +$760K |
|
2217
Concentrix
CNXC
$1.65B
| $1.24M | ﹤0.01% |
55,433
+16,096
| +41% | +$420K |
|
2218
Lincoln Educational Services
LINC
$712M
| $1.24M | ﹤0.01% |
24,811
+3,685
| +17% | +$167K |
|
2219
Navient
NAVI
$855M
| $1.24M | ﹤0.01% |
145,480
+23,542
| +19% | +$198K |
|
2220
PagSeguro Digital
PAGS
$2.49B
| $1.24M | ﹤0.01% |
136,679
-927,516
| -87% | -$8.97M |
|
2221
Eagle Bancorp
EGBN
$870M
| $1.24M | ﹤0.01% |
43,492
+7,876
| +22% | +$211K |
|
2222
Omeros
OMER
$1.45B
| $1.23M | ﹤0.01% |
129,550
+22,257
| +21% | +$265K |
|
2223
Fidelity MSCI Information Technology Index ETF
FTEC
$22.1B
| $1.23M | ﹤0.01% |
4,302
| – | – |
|
2224
Hippo Holdings
HIPO
$808M
| $1.23M | ﹤0.01% |
43,361
+13,650
| +46% | +$363K |
|
|
KE
2225
Kimball Electronics
KE
$654M
| $1.22M | ﹤0.01% |
47,791
+8,014
| +20% | +$206K |
|
Similar funds
T. Rowe Price Associates's Q2 2026 Portfolio in Review
As of Q2 2026, T. Rowe Price Associates held 3,356 positions worth $999B, up 16% from $865B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q2 2026 filing shows 224 new, 2,237 increased, 645 reduced and 116 closed positions. Its largest new stake was SpaceX: 10,709,016 shares worth $1.83B. The largest sale was Microsoft, an estimated $12.1B.
By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 34% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2026 buy was SpaceX: 10,709,016 shares worth $1.83B.
- T. Rowe Price Associates added most to Alphabet (Google) Class A in Q2 2026, an estimated $7.49B increase.
- T. Rowe Price Associates's biggest Q2 2026 reduction was Microsoft, cutting an estimated $12.1B.
- T. Rowe Price Associates fully exited Sibanye-Stillwater in Q2 2026, selling an estimated $40.4M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $999B portfolio in Q2 2026.
- T. Rowe Price Associates opened 224 new positions and closed 116 in Q2 2026.
- T. Rowe Price Associates's portfolio value rose 16% quarter-over-quarter to $999B.
Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.